Want to see ADUS full AI Analyst Report?
ADUS Stock Chart & Stats
$115.65
$1.10(0.96%)
At close: 4:00 PM EDT
$115.65
$1.10(0.96%)
Day’s Range― - ―
52-Week Range$87.95 - $124.44
Previous CloseN/A
Volume170.02K
Average Volume (3M)259.75K
Market Cap
$2.26B
Enterprise Value$1.87K
Total Cash (Recent Filing)$99.57M
Total Debt (Recent Filing)$108.82M
Price to Earnings (P/E)21.3
Beta0.33
Next Earnings
Nov 02, 2026EPS Estimate
1.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.68
Shares Outstanding18,674,300
10 Day Avg. Volume237,150
30 Day Avg. Volume259,747
Financial Highlights & Ratios
PEG Ratio1.04
Price to Book (P/B)1.83
Price to Sales (P/S)1.39
P/FCF Ratio19.09
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$127.43Price Target Upside10.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)7
Revenue Forecast (FY)$1.52B
Bulls Say, Bears Say
Bulls Say
Balance-sheet Deleveraging & LiquidityA dramatic reduction in debt and a stronger equity base materially lowers financial risk, reduces interest expense sensitivity, and expands strategic optionality. This durable improvement supports M&A, organic investment, and resilience to reimbursement or volume shocks over the next several quarters.
Strong Cash Generation And FCFConsistently robust operating and free cash flow underpins the company’s ability to fund capex, pursue accretive acquisitions, and maintain liquidity without relying on external financing. Close FCF-to-income conversion signals durable earnings quality and financial flexibility.
Personal-care Growth Plus M&A MomentumOrganic same-store growth in the core personal-care segment, combined with targeted tuck-in acquisitions, supports scalable revenue growth and density gains in state markets. This durable model leverages reimbursement tailwinds and a rolloutable operating playbook for long-term expansion.
Bears Say
Payor Concentration / Reimbursement RiskA business model tied heavily to Medicaid/Medicare reimbursement exposes margins and volume to state budget cycles, rate-setting and policy changes. Over a multi-month horizon, slower or lower-than-expected reimbursement adjustments could erode profitability and constrain funding for growth.
Elevated DSOs And Working-capital VariabilityA material rise in receivable days increases cash conversion risk and makes free cash flow less predictable. Even with strong liquidity, sustained DSO volatility stresses operations, may require higher credit usage, and weakens the company's ability to fund near-term acquisitions or absorb reimbursement timing shifts.
Under‑scaled, Declining Home‑health SegmentA small, shrinking home-health business limits the company's ability to offer a fully integrated continuum of care and reduces diversification of payor and service mix. Persistent underperformance in this segment could cap margin upside and force more acquisition-driven fixes.
Addus Homecare News
ADUS FAQ
What was Addus Homecare’s price range in the past 12 months?
Addus Homecare lowest stock price was $87.95 and its highest was $124.44 in the past 12 months.
What is Addus Homecare’s market cap?
Addus Homecare’s market cap is $2.26B.
When is Addus Homecare’s upcoming earnings report date?
Addus Homecare’s upcoming earnings report date is Nov 02, 2026 which is in 71 days.
How were Addus Homecare’s earnings last quarter?
Addus Homecare released its earnings results on Aug 03, 2026. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.698 by $0.032.
Is Addus Homecare overvalued?
According to Wall Street analysts Addus Homecare’s price is currently Undervalued.
Does Addus Homecare pay dividends?
Addus Homecare does not currently pay dividends.
What is Addus Homecare’s EPS estimate?
Addus Homecare’s EPS estimate is 1.79.
How many shares outstanding does Addus Homecare have?
Addus Homecare has 18,674,300 shares outstanding.
What happened to Addus Homecare’s price movement after its last earnings report?
Addus Homecare reported an EPS of $1.73 in its last earnings report, beating expectations of $1.698. Following the earnings report the stock price went down -2.68%.
Which hedge fund is a major shareholder of Addus Homecare?
Currently, no hedge funds are holding shares in ADUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Addus Homecare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$127.43 (10.18% Upside)
$127.43 (10.18% Upside)
Blogger Sentiment
Bullish
ADUS Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 6.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $46.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.38%
Trailing 12-Months
Company Description
Addus Homecare
Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.
ADUS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid top-line growth (+7.7% revenue), meaningful EPS and adjusted EBITDA improvements, strong operating cash flow ($52.4M) and a strengthened balance sheet with reduced bank debt and sizable revolver availability. Personal Care and Hospice were key growth drivers (Personal Care same-store +6.5%; Hospice ADC +8.2%). Management also highlighted progress on productivity (caregiver app), hiring, and targeted M&A (entry into Indiana). Challenges noted include a weather-driven $1.5M revenue hit, elevated DSOs (timing-driven), a YoY decline in home health revenue, and a reversion in hospice revenue-per-day dynamics. Overall, positives (multiple strong metrics, cash flow and M&A runway, operating improvements) outweigh the contained challenges and one-time items.View all ADUS earnings summariesADUS Stock 12 Month Forecast
Average Price Target
$127.43
▲(10.18% Upside)
Technical Analysis
National Healthcare
―
―
US Physical Therapy
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.87% Insiders
36.63% Mutual Funds
32.26% Other Institutional Investors
4.21% Public Companies and
Individual Investors